Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2024-04-11 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
PR FMR 11.04.24 ENG.pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparency notification' issued by UCB SA/NV announcing that FMR LLC's shareholding crossed the 5% threshold following an acquisition. It details the number of voting rights held by FMR LLC and its affiliates, the date the threshold was crossed (5 April 2024), and the previous holding percentage. This content directly relates to changes in significant share ownership, which aligns perfectly with the definition of Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a general regulatory filing (RNS), as it concerns a specific insider/major shareholder transaction disclosure requirement.
2024-04-11 English
CdP FMR 11.04.24 FR.pdf
Director's Dealing Classification · 1% confidence The document is titled "Notification de transparence FMR LLC" and explicitly states it is an "Information réglementée" (Regulated Information). The content details the acquisition of voting shares by FMR LLC, causing its stake to cross the 5% threshold, referencing Belgian law regarding the disclosure of significant shareholdings ("loi du 2 mai 2007 relative à la publicité des participations importantes"). This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of a Major Shareholding Notification (MRQ). It is not an earnings release, annual report, or a general regulatory filing (RNS), as it fits a specific category.
2024-04-11 French
PB FMR 11.04.24 NL.pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) issued by UCB NV, dated April 11, 2024, concerning a notification received from FMR LLC regarding a change in shareholding. Specifically, it details that FMR LLC's stake in UCB NV crossed the 5% threshold on April 5, 2024, detailing the exact number of voting rights held (7.28%). This type of mandatory disclosure regarding changes in significant share ownership, often triggered by crossing statutory thresholds (like 5% in this case, referencing Belgian law), directly corresponds to the definition of a Major Shareholding Notification. The filing type code for Major Shareholding Notification is MRQ.
2024-04-11 Dutch
240405 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly discusses the 'Acquisition of own shares' under a 'Share Repurchase Program 2024'. It details the number of shares repurchased, the dates (April 2 to April 4, 2024), average prices, and total costs. This activity directly corresponds to the definition of a company buying back its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is a formal disclosure of this transaction.
2024-04-05 English
240405 - Acquisition actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres" (Share Buyback) and explicitly details the number of shares repurchased by UCB SA on Euronext Brussels between April 2nd and April 4th, 2024, including transaction dates, quantities, and prices. This directly corresponds to the definition of a company reporting transactions in its own shares. The filing type code POS (Transaction in Own Shares) is the most appropriate classification.
2024-04-05 French
240405 - Verwerving van eigen aandelen_NL .pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Verwerving van eigen aandelen" (Acquisition of own shares) and details the number of shares UCB NV repurchased on Euronext Brussels between April 2, 2024, and April 4, 2024, including transaction dates, volumes, and prices. This activity directly corresponds to the definition of a company buying back its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification for this specific disclosure.
2024-04-05 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.